NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000346

Registered date:01/04/2006

A randomized clinical trial of adjuvant chemotherapy with TS-1 versus UFT following curative operation for Stage III colorectal cancer

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedstage III colorectal cancer
Date of first enrollment2005/07/01
Target sample size200
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)UFT 400mg/m2/day 5days' medication, 2days' rest Start medication within 6weeks postoperatively, continue for 12months TS-1 80mg/m2/day 28days' medication, 14days' break Start medication within 6weeks postoperatively, continue for 12months

Outcome(s)

Primary Outcome3-year disease free survival
Secondary Outcomeoverall survival

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria:patients with hypersensitivity or allergy to any medicine :Pts. with myelosupression, renal dysfuction, or liver dysfuncion :Pts. with severe postoperative complications :Pt. who is pregnant or is to be pregnant :Pts. with multiple cancers :Pts. who are taking other fluoropyrimidine derivatives :Pts. with severe infection or inflammation :doctor's decision for exclusion

Related Information

Contact

public contact
Name Keiji Koda
Address 1-8-1 Inohana, Chuo-Ku, Chiba City, Japan Japan
Telephone 043-293-0086
E-mail k-koda@umin.ac.jp
Affiliation Boso Clinical Oncology Group The nonprofit organization
scientific contact
Name Hisahiro Matsubara
Address 1-8-1 Inohana, Chuo-Ku, Chiba City, Japan Japan
Telephone 043-222-7171
E-mail matsuhm@faculty.chiba-u.jp
Affiliation Boso Clinical Oncology Group The nonprofit organization